Skip to main content
. 2018 May 29;10:1351–1358. doi: 10.2147/CMAR.S161501

Table 8.

Correlation between MUC1 expression and BRAF status in 486 PTC patients from TCGA database

Variables MUC1 (+) BRAF (+)
n=203
MUC1 (+) BRAF (−)
n=40
MUC1 (−) BRAF (+)
n=76
MUC1 (−) BRAF (−)
n=167
P-valuea P-valueb P-valuec P-valued
Size (cm) 2.9±1.7 3.0±1.6 2.6±1.6 2.8±1.6 0.817 0.337 0.062 0.521
Age (years) 48.8±16.0 42.3±16.6 44.7±12.8 47.8±16.3 0.021 0.136 0.046 0.055
Extrathyroid extension 0.378 0.021 0.009 0.002
 Yes, n (%) 89 (44.9) 14 (36.8) 21 (27.6) 23 (14.7)
 No, n (%) 109 (55.1) 24 (63.2) 55 (72.4) 133 (85.3)
Gender 0.188 0.748 0.363 0.075
 Male, n (%) 58 (28.6) 16 (40) 17 (22.4) 41 (24.6)
 Female, n (%) 145 (71.4) 24 (60) 59 (77.6) 126 (75.4)
Lymph node metastasis 1 <0.001 0.396 <0.001
 Yes, n (%) 113 (60.8) 24 (61.5) 39 (54.9) 39 (27.6)
 No, n (%) 73 (39.2) 15 (38.5) 32 (45.1) 102 (72.3)

Notes: MUC1 (+) = high expression of MUC1, MUC1 (−) = low expression of MUC1, BRAF (+) = BRAF mutation, BRAF (−) = BRAF wild type.

a

P value represents MUC1 (+) BRAF (+) versus MUC1 (+) BRAF (−).

b

P value represents MUC1 (−) BRAF (+) versus MUC1 (−) BRAF (−).

c

P value represents MUC1 (+) BRAF (+) versus MUC1 (−) BRAF (+).

d

P value represents MUC1 (+) BRAF (−) versus MUC1 (−) BRAF (−).

Abbreviations: MUC1, mucin 1; PTC, papillary thyroid cancer; TCGA, The Cancer Genome Atlas.